SYNH

Q: What is the price of Syneos Health (SYNH) today?

The current price of Syneos Health (SYNH) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Syneos Health (SYNH) pay dividends?

Syneos Health (SYNH) did not pay dividends over the past year.

Q: Is Syneos Health (SYNH) a good investment?

Syneos Health (SYNH) is currently trading at $ 0.00 with a P/E ratio of 62.97. This represents a 3,859% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Syneos Health Inc.

Price

$ -

return (12m)

0.00%

p/e

62.97

p/bv

1.28

DIVIDEND YIELD

0.00%

SYNH price

Syneos Health

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SYNH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals SYNH

review the fundamentals of Syneos Health shares

P/E

62.97

Sector: -2.40 Industry: 7.44

P/S (PSR)

0.83

Sector: 1.94 Industry: 3.07

P/BV

1.28

Sector: 2.11 Industry: 3.12

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

0.88%

Sector: -28.57% Industry: -3.96%

ROE

2.04%

Sector: -35.14% Industry: -15.35%

ROIC

Sector: -439.49% Industry: -13.19%

NET MARGIN

1.31%

Sector: -31.27% Industry: -7.51%

GROSS MARGIN

40.92%

Sector: 44.47% Industry: 54.39%

OPERATING MARGIN

4.41%

Sector: -26.20% Industry: -3.69%

EV/EBITDA

21.31

Sector: -0.60 Industry: 7.50

EV/EBIT

-131.01

Sector: -2.30 Industry: 7.06

PRICE-TO-ASSETS

0.56

Sector: 1.14 Industry: 1.27

BVPS

33.48

Sector: 3.75 Industry: 8.68

EPS

0.68

Sector: -0.94 Industry: 0.05

EQUITY-TO-ASSETS RATIO

0.43

Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

0.43

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

0.78%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-21.23%

Sector: - Industry: -

FAIR VALUE OF Syneos Health ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 0.00

Fair Value

$ 22.63

Upside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SYNH

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	39.95	32.37	81.02%	0.55%	$ 1.01 T	34.99%
ISRG	50.29	8.51	16.93%	0.00%	$ 149.83 B	28.15%
SNY	7.36	1.31	17.79%	8.84%	$ 109.89 B	14.75%
TMO	25.68	3.38	13.15%	0.37%	$ 175.88 B	15.15%
NVS	21.04	7.31	34.77%	2.08%	$ 284.75 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
GSK	13.10	4.42	33.77%	3.43%	$ 102.78 B	17.79%
CVS	41.65	1.57	3.78%	2.77%	$ 122.12 B	0.72%
BSX	19.67	2.71	13.78%	0.00%	$ 70.13 B	17.29%
TMDX	13.73	4.78	34.80%	0.00%	$ 2.36 B	27.04%
IDXX	41.06	28.90	70.38%	0.00%	$ 44.97 B	24.63%
HCA	12.27	-27.99	-228.14%	0.79%	$ 83.36 B	8.89%
RMD	18.65	4.37	23.41%	1.19%	$ 28.34 B	27.44%
DHR	35.37	2.46	6.97%	0.74%	$ 130.48 B	14.89%
INMD	9.78	1.29	13.18%	0.00%	$ 853.02 M	23.27%
PHG	22.01	1.88	8.56%	3.88%	$ 24.87 B	5.50%
SYK	34.98	5.08	14.52%	1.13%	$ 116.73 B	13.21%
CI	11.78	1.81	15.39%	2.10%	$ 76.49 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SYNH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Syneos Health

Syneos Health Inc.

Average Investor10 user rating

4.0 (0 people)

United States

16 years

Founded: 2010

2014

Time since IPO - 12 years

6.800

Employees

Syneos Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.48 Billions, with shareholders equity totaling $3.49 Billions.

The company employs approximately 6.800 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Syneos Health Inc. reported $5.42 Billions in revenue, generating net income of $71.22 Millions.

Key financial metrics include a P/E ratio of 62.97, a price-to-book (P/B) ratio of 1.28, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SYNH.

Market cap

$ 4.48 Billions

Net worth

$ 3.49 Billions

$ 3,493,754,000.00

Assets

$ 8.08 Billions

$ 8,075,381,000.00

Total Shares Outstanding

104.34 Millions

104,344,000

Average Daily Trading Volume

$ 1.29 Million

$ 1,293,527.04

Sector

Health

Industry

Life Science Tools and Services

SYNH

SYNH revenue and profits

Financial Results SYNH

DRAG THE FRAME TO SEE MORE DATA

SYNH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CI - Cigna

$ 298.00 --3,58% (12M)

P/E

11.78

2.10%

ROE

15.39%

P/BV

1.81

ABT - Abbott

$ 88.18 --33,64% (12M)

P/E

23.76

2.85%

ROE

11.91%

P/BV

2.83

BSX - Boston Scientific

$ 46.91 --52,97% (12M)

P/E

19.67

0.00%

ROE

13.78%

P/BV

2.71

BDXB - Becton Dickinson

$ - -0,00% (12M)

P/E

8.75

0.00%

ROE

6.12%

P/BV

0.54

COHR - Coherent

$ 385.03 397,65% (12M)

P/E

156.03

0.00%

ROE

4.26%

P/BV

6.64

ALXN - Alexion Pharmaceuticals

$ - -0,00% (12M)

P/E

58.89

0.00%

ROE

5.48%

P/BV

3.23

PDCO - Patterson Companies

$ - -0,00% (12M)

P/E

19.87

2.49%

ROE

14.02%

P/BV

2.79

ENSG - Ensign Group

$ 149.37 --1,09% (12M)

P/E

23.84

0.17%

ROE

15.33%

P/BV

3.66